Guohong Han Selected Research

Guohong Han Research Topics

Disease

32	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 08/2012
31	Hemorrhage 10/2023 - 01/2011
29	Fibrosis (Cirrhosis) 10/2023 - 01/2011
23	Thrombosis (Thrombus) 12/2023 - 02/2010
21	Hepatic Encephalopathy 01/2023 - 06/2010
17	Neoplasms (Cancer) 01/2024 - 01/2008
14	Ascites 09/2023 - 01/2011
14	Portal Hypertension 01/2023 - 11/2010
10	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 01/2011
7	Budd-Chiari Syndrome (Budd Chiari Syndrome) 01/2019 - 03/2013
5	Pancreatic Neoplasms (Pancreatic Cancer) 12/2017 - 01/2008
4	Varicose Veins (Varicose Vein) 01/2021 - 03/2014
4	Liver Neoplasms (Liver Cancer) 01/2016 - 12/2013
3	Fatigue 07/2022 - 01/2016
3	End Stage Liver Disease 05/2022 - 01/2021
3	Liver Diseases (Liver Disease) 01/2019 - 01/2016
3	Diarrhea 01/2019 - 03/2013
3	Hypertension (High Blood Pressure) 01/2018 - 11/2014
3	Liver Failure 01/2017 - 04/2012
3	Brain Diseases (Brain Disorder) 01/2017 - 11/2010
2	Infections 01/2021 - 04/2012
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 07/2020 - 01/2015
2	Adenocarcinoma 12/2017 - 12/2013
2	Disease Progression 01/2016 - 03/2013
2	Fever (Fevers) 01/2016 - 03/2013
2	Carcinogenesis 10/2011 - 01/2008
2	Stomach Neoplasms (Stomach Cancer) 02/2009 - 01/2008
1	Dysbiosis 05/2022
1	Gastritis 01/2022
1	Peptic Ulcer (Peptic Ulcers) 01/2022
1	Hypoalbuminemia 01/2021
1	COVID-19 01/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2020
1	Rheumatoid Arthritis 01/2020
1	Arthritis (Polyarthritis) 01/2020
1	Peritonitis 01/2019
1	Idiopathic Noncirrhotic Portal Hypertension 01/2019
1	Hepatorenal Syndrome 01/2019
1	Hydrothorax 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Muscle Spasticity (Spastic) 01/2019
1	Spinal Cord Diseases 01/2019

Drug/Important Bio-Agent (IBA)

18	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 08/2012
6	BilirubinIBA 05/2022 - 09/2014
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 02/2009
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2018
3	AlbuminsIBA 01/2021 - 01/2020
3	Protein SIBA 07/2020 - 03/2013
3	Protein CIBA 07/2020 - 03/2013
3	AntithrombinsIBA 07/2020 - 03/2013
3	thiamine triphosphorate (TTP)IBA 06/2020 - 01/2016
3	AnticoagulantsIBA 01/2019 - 08/2012
3	Propranolol (Inderal)FDA LinkGeneric 01/2019 - 03/2014
3	brivanibIBA 11/2014 - 03/2014
2	lenvatinibIBA 07/2022 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2022 - 01/2021
2	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2016
2	Alkaline PhosphataseIBA 01/2021 - 02/2013
2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021 - 01/2019
2	Prothrombin (Factor II)IBA 07/2020 - 01/2015
2	factor V LeidenIBA 07/2020 - 01/2015
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 02/2016
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 01/2016
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2018 - 01/2016
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 01/2016
2	AntigensIBA 07/2016 - 01/2015
2	EmulsionsIBA 05/2013 - 03/2013
2	Ethiodized Oil (Ethiodol)FDA Link 05/2013 - 03/2013
2	Carrier Proteins (Binding Protein)IBA 10/2011 - 01/2008
2	S100 Calcium Binding Protein A6IBA 10/2011 - 01/2008
2	UbiquitinIBA 10/2011 - 01/2008
2	Small Interfering RNA (siRNA)IBA 10/2011 - 02/2009
2	beta CateninIBA 10/2011 - 01/2008
2	Proteins (Proteins, Gene)FDA Link 10/2011 - 01/2008
1	lactitolIBA 01/2023
1	SodiumIBA 12/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	RivaroxabanIBA 01/2021
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 06/2020
1	glycol-chitosanIBA 01/2020
1	CollagenIBA 01/2020
1	CytokinesIBA 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	capmatinibIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	Serum AlbuminIBA 01/2019

Therapy/Procedure

48	Transjugular Intrahepatic Portasystemic Shunt 12/2023 - 11/2010
45	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2023 - 02/2010
20	Therapeutics 01/2023 - 01/2011
14	Stents 01/2022 - 11/2010
3	Liver Transplantation 01/2023 - 04/2011
3	Splenectomy 07/2016 - 06/2012
2	Ligation 01/2019 - 12/2018
2	Conservative Treatment 01/2014 - 08/2012
2	Drug Therapy (Chemotherapy) 05/2013 - 02/2009
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Transplantation 01/2019